# Cue Biopharma, Inc.: Form 8-K, filed Apr 22, 2026

- Company: [Cue Biopharma, Inc.](/companies/cue.md) (CIK 1645460)
- Form: 8-K
- Filed: 2026-04-22
- Accepted by EDGAR: Apr 22, 2026, 12:47 ET
- Period: 2026-04-22
- Accession: 0001193125-26-168907
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645460/000119312526168907/cue-20260422.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645460/000119312526168907/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645460/000119312526168907/cue-20260422.htm

Filed Apr 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-168907. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.